Thus, while cancer cells that synthesize ATP by glycolysis may achieve increased resistance to cell death by MCU inhibition, malignant cells that primarily rely on mitochondrial respiration for ATP synthesis are expected to require a hyperactive MCU complex (upon MCU upregulation or MICU1 downregulation), calling for the establishment of alternative cytoprotective pathways. The gene discussed is MICU1; the disease is cancer.